Inventiva S.A. American Depository Shares (IVA) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Obsidian Therapeutics is the larger company by market cap ($815.4 million vs $794.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IVA | OBX |
|---|---|---|
| Share price | $3.37 | $13.20 |
| Market cap | $794.88M | $815.40M |
| 1-day change | -2.75% | -0.15% |
| YTD return | -27.63% | — |
| 1-year return | -39.04% | — |
| 5-year return | -74.89% | — |
| EPS (TTM) | $-0.62 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.98 | $49.97 |
| 52-week low | $3.11 | $12.16 |
| Distance from 52-week high | -57.85% | -73.58% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +351.71% | +195.45% |
| Average volume | 1.37M | 364.58K |
| Shares outstanding | 236.22M | 61.77M |
| Employees | 87 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Inventiva S.A. American Depository Shares
IVA stock →Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
IVA vs OBX FAQ
Which is bigger, Inventiva S.A. American Depository Shares or Obsidian Therapeutics?
Obsidian Therapeutics (OBX) is larger, with a market capitalization of $815.40M compared with $794.88M for Inventiva S.A. American Depository Shares (IVA).
Are Inventiva S.A. American Depository Shares and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.